9267 · Genky DrugStores Co., Ltd. · Financials
Market Cap
114.27B JPY
Shares
30.51M
Volume · Nov 11
90.9K
Avg daily vol (3M)
78.12K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
220.64B
+9.9%
FY2026
Net Income
7.88B
+11.4%
FY2026
Gross Margin
20.36%
0pp
FY2026
Operating Margin
4.98%
+0.2pp
FY2026
Operating Cash Flow
16.98B
+34.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 220.64B | 200.79B | 184.86B | 169.06B | 154.64B |
| JPY | 175.72B | 159.9B | 147.24B | 134.51B | 123.69B |
| JPY | 44.92B | 40.89B | 37.62B | 34.55B | 30.95B |
| JPY | 10.99B | 9.66B | 9.02B | 6.71B | 5.68B |
| JPY | 11.15B | 9.9B | 8.8B | 6.7B | 6.08B |
| JPY | 3.28B | 2.84B | 2.48B | 1.94B | 1.66B |
| JPY | 7.88B | 7.07B | 6.32B | 4.76B | 4.42B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.93B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.